Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Is A Blow-Off Top Setting Up

Our research team has become increasingly concerned that the US Fed support for the markets has pushed price levels well above true valuation levels and that a risk of a downside price move is still rather high. Recently, we published a research article highlighting our Adap...
Chris Vermeulen | May 26, 2020 |

Threat Detection Technology Designed to Save Lives

Hot-on-the-heels of their public listing in January, First Responder Technologies Inc. ( CSE:WPN , Forum ) announced key recruitments to their advisory board and plans to demonstrate the world’s first WiFi-based walk-through metal detector in the UK, ...
Dave Jackson | February 19, 2020 |

Aravive Shares Rise on Positive Patient Data from Phase 1b Ovarian Cancer Study

Shares of Aravive Inc. are trading higher after the firm posted positive data from the initial 12 patients enrolled in the Phase 1b portion of its study of AVB-500 used in the treatment of ovarian cancer. Today, in a late-breaking oral presentation at the European Soc...
Streetwise Reports | September 30, 2019 |

Exciting Results from One of Ontario’s Newest Gold Explorers

(Image via Cross River Ventures Corp.) For most of October 2020, gold prices have been stuck around $1,900 / Oz. mainly due to the strength of the US dollar, though analysts now expect the price of gold to jump in the next few weeks and yield a “lasting price upswing&...
Stockhouse Editorial | October 20, 2020 |

Fibonacci Predictive Modeling Suggests Price Volatility Will Continue

We believe price volatility may surprise many traders throughout the end of this year. Our proprietary Fibonacci price modeling system is suggesting that price must rotate dramatically higher or lower to establish any new confirmed price trends. The Fibonacci price modeling sy...
Chris Vermeulen | September 30, 2019 |

Kodiak Shares Soar on $225 Million Royalty Deal for Retinal Drug

Shares of Kodiak Sciences traded more than 100% higher at times after the company reported that it entered into a $225 million royalty agreement for the firm's KSI-301 used in the treatment of retinal vascular diseases including age-related macular degeneration and diabetic ey...
Streetwise Reports | December 3, 2019 |

Inovio Pharma Awarded $9M Development Grant for Coronavirus Vaccine

Inovio Pharmaceuticals' shares rose 30%, setting a new 52-week high price, after the firm reported it received a grant of up to $9 million to develop a vaccine against the coronavirus. Among ongoing worldwide concerns, biotechnology firm Inovio Pharmaceuticals Inc. (IN...
Streetwise Reports | January 28, 2020 |

Bellerophon Shares Take Off as FDA Grants Emergency Expanded Access for INOpulse for COVID-19 ...

Bellerophon Shares Take Off as FDA Grants Emergency Expanded Access for INOpulse for COVID-19 Treatment Shares of Bellerophon Therapeutics reached a new 52-week high price after the firm reported that the FDA granted emergency expanded access for its INOpulse®...
Streetwise Reports | March 23, 2020 |

Immunomedics Shares Double as Phase 3 Breast Cancer Trial Achieves 'Compelling' Efficacy Data

Shares of Immunomedics opened 117% higher after the company reported that it has stopped its Phase 3 ASCENT study of sacituzumab govitecan after recording "compelling evidence of efficacy" in heavily pretreated patients with metastatic triple-negative breast cancer. ...
Streetwise Reports | April 7, 2020 |

The Coronavirus and Gold

Rudi Fronk and Jim Anthony, cofounders of Seabridge Gold, discuss movements in the gold markets since the onset of the coronavirus pandemic. In mid-January, 2020, COMEX open interest (OI) set a new record of nearly 800,000 contracts. Swap dealers as usual supplied ...
Streetwise Reports | June 9, 2020 |
1 2 3 4 5 6 7 8 9 10 ...